GMP IPO
📋 Filings Intelligence
About Contact
LIVE — Auto-updated every 10 mins · Equity segment
Company Filings, Explained Simply

AI-powered plain-English analysis of every important corporate announcement — financial results, order wins, dividends, mergers and more. Updated live.

—
Filed today
—
Companies tracked
NSE & BSE
Listed on
Sign in free to search by company
Filing Type
Market Cap
Sector
All Sectors

Latest Filings —

📋 Filing Types Available on ForgeUp Filings Sourced from BSE corporate announcements (equity segment). Companies covered are BSE-listed and most are also listed on NSE. We show only material filings.
Financial Results Orders Dividend Buyback Merger / Acquisition Board Meeting Outcome Fundraise (QIP / Rights / FPO) Regulatory / Court Order Credit Rating Change Promoter Pledge Update Management Change Joint Venture / MOU Delisting Bonus Shares Stock Split
Data sourced from BSE India corporate announcements. More categories will be added over time.
Genomic Valley Biotech Ltd

Genomic Valley Biotech: Q2 FY27 and H1 FY27 Unaudited Financial Results Published

RESULTS ● No Immediate Change LOW RISK
📅 Filed on BSE: 02 Nov 2026, 05:00 PM IST  ·  BSE ID: ba57fc7d-81ee-4bcc-a9c3-208a5804f00c
View Original BSE Filing (PDF)
💡
In Simple Terms
The company released its financial report for the July-September 2026 quarter and the first half of its financial year.
🤖 AI Summary
  • Genomic Valley Biotech Ltd. published standalone unaudited financial results for Q2 FY27.
  • Results cover the quarter and half year ended September 30, 2026.
  • Notification to BSE Limited confirmed newspaper advertisements of the financial results.
  • Advertisements were published in English (Financial Express) and Hindi (Jansatta) editions.
  • Managing Director Yogesh Agrawal signed the intimation to BSE Limited.
👥 What This Means For Shareholders
✅
Action Required
Shareholders do not need to take any direct action based on this filing, which is a compliance update.
👤
Who Is Affected
All shareholders are informed that the Q2 FY27 and H1 FY27 financial results have been published as per regulatory requirements.
🔍
Management Signal
The management's action indicates adherence to SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, specifically Regulation 47 for results publication.

For information only. Not investment advice. ForgeUp is not SEBI-registered.

👁 Watch List — track these upcoming events
Review Q2 FY27 and H1 FY27 unaudited financial results for detailed figures.
Monitor future filings for any significant operational or financial updates.
Watch for Q3 FY27 unaudited financial results filing around January 2027.
LOW RISK This is a compliance filing regarding results publication, not an event with inherent risk.
💡 Investor Takeaway
Genomic Valley Biotech Ltd. confirmed the publication of its standalone unaudited financial results for the quarter and half year ended September 30, 2026. This filing adheres to Regulation 47 of SEBI (LODR) Regulations, 2015, by providing newspaper advertisement clippings.
📅 Company Track Record
Genomic Valley Biotech Ltd.'s Board approved the Q2 & H1 FY27 unaudited financial results on October 30, 2026, as per a previous filing. Prior to this, the Board had scheduled a meeting on August 14, 2026, to approve Q1 FY27 unaudited results.

Based on publicly available historical data. For context only.

❓ Frequently Asked Questions
What financial period do these results cover for Genomic Valley Biotech?
These results cover the unaudited financial performance for the quarter and half year ended on September 30, 2026, which corresponds to Q2 FY27 and H1 FY27.
Where were Genomic Valley Biotech's financial results advertised?
The unaudited financial results were advertised in English (Financial Express) editions and Hindi (Jansatta) Regional Language editions on September 01, 2026.
Which regulation mandates this publication by Genomic Valley Biotech?
This publication is pursuant to Regulation 47 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Questions based on this BSE filing only. For information purposes.

You've read one filing

There are 32,000 more, and one of them is about a company you own

Follow a company and we'll email you the moment it files again — explained, not just forwarded. Free.

  • Follow companies and get filings by email
  • Save any filing to read later
  • Two full AI analyses every month, free

No card needed. Sign in with Google in two taps.

⚠️ For Information Only — Not Investment Advice
ForgeUp Filings provides AI-generated summaries of public BSE exchange announcements (equity segment) for informational purposes only. Nothing here constitutes investment advice or a recommendation to buy, sell, or hold any security. ForgeUp is not a SEBI-registered investment advisor. All financial numbers are sourced directly from BSE filings and shown as-is. Past data is historical only. Please consult a qualified financial advisor before making investment decisions. Data sourced from BSE India public disclosures.
🔍
Sign in to use filters
Sign in free with Google to filter filings by category, market cap and sector — takes 5 seconds.